Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 4/2002

01-04-2002

Infection by CagA-Positive Helicobacter pylori Strains in Patients with Ischemic Heart Disease: Prevalence and Association with Exercise-Induced Electrocardiographic Abnormalities

Authors: N. Figura, A. Palazzuoli, S. Faglia, C. Lenzi, F. Borrello, V. Palazzuoli, R. Nami, N. Dal Canto, F. De Regis, D. Vaira, L. Gennari, N. Giordano, C. Gennari

Published in: Digestive Diseases and Sciences | Issue 4/2002

Login to get access
Metadata
Title
Infection by CagA-Positive Helicobacter pylori Strains in Patients with Ischemic Heart Disease: Prevalence and Association with Exercise-Induced Electrocardiographic Abnormalities
Authors
N. Figura
A. Palazzuoli
S. Faglia
C. Lenzi
F. Borrello
V. Palazzuoli
R. Nami
N. Dal Canto
F. De Regis
D. Vaira
L. Gennari
N. Giordano
C. Gennari
Publication date
01-04-2002
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Digestive Diseases and Sciences / Issue 4/2002
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1023/A:1014708520885

Other articles of this Issue 4/2002

Digestive Diseases and Sciences 4/2002 Go to the issue

OriginalPaper

Unchanging Trend of Adenocarcinoma of the Esophagus and Gastric Cardia in Taiwan: A 15-Year Experience in a Single Center

OriginalPaper

Evolution of Visceral Sensitivity in Patients with Irritable Bowel Syndrome

OriginalPaper

Effects of Gabexate Mesilate, a Protease Inhibitor, on Human Sphincter of Oddi Motility

OriginalPaper

Butyrate Strongly Inhibits In Vitro Stimulated Release of Cytokines in Blood

OriginalPaper

IgA Against Gut-Derived Endotoxins: Does It Contribute to Suppression of Hepatic Inflammation in Alcohol-Induced Liver Disease?

OriginalPaper

Long-Term Rebamipide Therapy Improves Helicobacter pylori-Associated Chronic Gastritis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits